4.8 Editorial Material

Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases

Journal

HEPATOLOGY
Volume 71, Issue 2, Pages 757-759

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1002/hep.30904

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available